288 related articles for article (PubMed ID: 33419403)
1. Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
Solis-Pazmino P; Salazar-Vega J; Lincango-Naranjo E; Garcia C; Koupermann GJ; Ortiz-Prado E; Ledesma T; Rojas T; Alvarado-Mafla B; Carcamo C; Ponce OJ; Brito JP
BMC Cancer; 2021 Jan; 21(1):42. PubMed ID: 33419403
[TBL] [Abstract][Full Text] [Related]
2. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of differentiated thyroid carcinoma].
Mora J
Rev Esp Med Nucl; 2003; 22(5):349-59; quiz 360-2. PubMed ID: 14534014
[No Abstract] [Full Text] [Related]
4. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment.
Christakis I; Dimas S; Kafetzis ID; Roukounakis N
Ann R Coll Surg Engl; 2018 May; 100(5):357-365. PubMed ID: 29484944
[TBL] [Abstract][Full Text] [Related]
6. Management of differentiated thyroid cancer of the follicular epithelium.
Pacini F
Ann Med; 2012 Nov; 44(7):651-5. PubMed ID: 21668295
[TBL] [Abstract][Full Text] [Related]
7. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract][Full Text] [Related]
8. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
9. Clinical behavior of follicular variant of papillary thyroid carcinoma: presentation and survival.
Lin HW; Bhattacharyya N
Laryngoscope; 2010 Apr; 120(4):712-6. PubMed ID: 20205241
[TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
11. Baseline stimulated thyroglobulin level as a good predictor of successful ablation after adjuvant radioiodine treatment for differentiated thyroid cancers.
Fatima N; uz Zaman M; Ikram M; Akhtar J; Islam N; Masood Q; Zaman U; Zaman A
Asian Pac J Cancer Prev; 2014; 15(15):6443-7. PubMed ID: 25124640
[TBL] [Abstract][Full Text] [Related]
12. Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis.
Muller S; Senne M; Kirschniak A; Königsrainer A; Bares R; Falch C
World J Surg Oncol; 2017 Oct; 15(1):190. PubMed ID: 29065879
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
[TBL] [Abstract][Full Text] [Related]
14. Treatment of locally aggressive well-differentiated thyroid cancer.
Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
[TBL] [Abstract][Full Text] [Related]
16. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
17. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
[TBL] [Abstract][Full Text] [Related]
18. Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence.
Enomoto K; Enomoto Y; Uchino S; Yamashita H; Noguchi S
Endocr J; 2013; 60(5):629-35. PubMed ID: 23327804
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.
Griniatsos J; Tsigris C; Kanakis M; Kaltsas G; Michail O; Dimitriou N; Argyrakopoulou G; Delladetsima I; Kyriakou V; Syriou V; Alexandraki K; Pikoulis E; Giannopoulos A; Kouraklis G; Diamanti-Kandaraki E; Felekouras E
Anticancer Res; 2009 Dec; 29(12):5163-9. PubMed ID: 20044632
[TBL] [Abstract][Full Text] [Related]
20. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]